These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25575079)

  • 21. Strategies to generate induced pluripotent stem cells.
    Hayes M; Zavazava N
    Methods Mol Biol; 2013; 1029():77-92. PubMed ID: 23756943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing Induced Pluripotent Stem Cell Generation by MicroRNA.
    Dang J; Rana TM
    Methods Mol Biol; 2016; 1357():71-84. PubMed ID: 25687299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of Footprint-Free Induced Pluripotent Stem Cells from Human Fibroblasts Using Episomal Plasmid Vectors.
    Ovchinnikov DA; Sun J; Wolvetang EJ
    Methods Mol Biol; 2015; 1330():37-45. PubMed ID: 26621587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocyte-like cells derived from induced pluripotent stem cells.
    Roy-Chowdhury N; Wang X; Guha C; Roy-Chowdhury J
    Hepatol Int; 2017 Jan; 11(1):54-69. PubMed ID: 27530815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.
    Brix J; Zhou Y; Luo Y
    J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
    Greder LV; Post J; Dutton JR
    Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A highly optimized protocol for reprogramming cancer cells to pluripotency using nonviral plasmid vectors.
    Zhao H; Davies TJ; Ning J; Chang Y; Sachamitr P; Sattler S; Fairchild PJ; Huang FP
    Cell Reprogram; 2015 Feb; 17(1):7-18. PubMed ID: 25549177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of induced pluripotent stem cells from common marmoset fibroblasts by RNA-based reprogramming.
    Nakajima M; Yoshimatsu S; Sato T; Nakamura M; Okahara J; Sasaki E; Shiozawa S; Okano H
    Biochem Biophys Res Commun; 2019 Aug; 515(4):593-599. PubMed ID: 31178141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolomic and Transcriptional Analyses Reveal Atmospheric Oxygen During Human Induced Pluripotent Stem Cell Generation Impairs Metabolic Reprogramming.
    Spyrou J; Gardner DK; Harvey AJ
    Stem Cells; 2019 Aug; 37(8):1042-1056. PubMed ID: 31042329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactivation of Endogenous Genes and Epigenetic Remodeling Are Barriers for Generating Transgene-Free Induced Pluripotent Stem Cells in Pig.
    Choi KH; Park JK; Son D; Hwang JY; Lee DK; Ka H; Park J; Lee CK
    PLoS One; 2016; 11(6):e0158046. PubMed ID: 27336671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GM-CSF and MEF-conditioned media support feeder-free reprogramming of mouse granulocytes to iPS cells.
    Firas J; Liu X; Nefzger CM; Polo JM
    Differentiation; 2014 Jun; 87(5):193-9. PubMed ID: 25015842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. cGMP-Compliant Expansion of Human iPSC Cultures as Adherent Monolayers.
    Parr AM; Walsh PJ; Truong V; Dutton JR
    Methods Mol Biol; 2016; 1357():221-9. PubMed ID: 25863788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scalable Expansion of Pluripotent Stem Cells.
    Lavon N; Zimerman M; Itskovitz-Eldor J
    Adv Biochem Eng Biotechnol; 2018; 163():23-37. PubMed ID: 29085956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology.
    Easley CA
    Methods Mol Biol; 2019; 1965():19-34. PubMed ID: 31069666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An improved method for generating integration-free human induced pluripotent stem cells].
    Liu SP; Li YX; Xu J; Gu HH; Zhang HY; Liang HY; Liu HZ; Zhang XB; Cheng T; Yuan WP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):580-7. PubMed ID: 24989258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of four integration-free iPSC lines from related human donors.
    Ramme AP; Faust D; Koenig L; Marx U
    Stem Cell Res; 2019 Dec; 41():101615. PubMed ID: 31704539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Derivation of induced pluripotent stem cells in Japanese macaque (Macaca fuscata).
    Nakai R; Ohnuki M; Kuroki K; Ito H; Hirai H; Kitajima R; Fujimoto T; Nakagawa M; Enard W; Imamura M
    Sci Rep; 2018 Aug; 8(1):12187. PubMed ID: 30111816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioprocessing considerations for generation of iPSCs intended for clinical application: perspectives from the ISCT Emerging Regenerative Medicine Technology working group.
    Song HW; Solomon JN; Masri F; Mack A; Durand N; Cameau E; Dianat N; Hunter A; Oh S; Schoen B; Marsh M; Bravery C; Sumen C; Clarke D; Bharti K; Allickson JG; Lakshmipathy U
    Cytotherapy; 2024 Nov; 26(11):1275-1284. PubMed ID: 38970614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.